About
Robopedics develops a lightweight robotic orthosis for hemiplegic stroke survivors that actuates the hip and knee of a single impaired limb to enable standing and walking at home as an alternative to full exoskeletons. The company positions the device as a low-cost, home-use assistive robotics solution (cited target price under €15,000 and weight ≈6 kg).
Explore Robopedics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.